Reverse transcriptase of HIV as a target for anti-viral drugs.
Darby
G
G
Department of Molecular Sciences, Wellcome Research Laboratories, Beckenham, Kent, U.K.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015224:Dideoxynucleosides / Q000494:pharmacology / Q000627:therapeutic use*; D015195:Drug Design; D006678:HIV / Q000187:drug effects* / Q000201:enzymology*; D006801:Humans; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine / Q000494:pharmacology / Q000627:therapeutic use
D000998:Antiviral Agents; D015224:Dideoxynucleosides; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine